House Panel Will Target FDA Device Efforts, Health Reform
This article was originally published in The Gray Sheet
Executive Summary
The House Energy and Commerce Committee plans to scrutinize FDA’s device approvals closely over the next two years, to be certain that extensive regulatory processes do not force industry jobs overseas, nor interfere with innovation, according to a committee oversight plan agreed to Feb. 15.